Karyopharm Therapeutics Inc. revenue breakdown overview

Karyopharm Therapeutics Inc. revenue for the last year amounted to 145.24 M USD, the most of which — 145.24 M USD — came from its highest performing source at the moment, Drugs, the year earlier bringing 146.03 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Karyopharm Therapeutics Inc. 145.24 M USD, and the year before that — 146.03 M USD.